Abstract: Provided a full-automatic wheel hub 3D scanning system for intelligent production line of automotive wheel hubs, comprising: a base plate is provided with an X-directional displacement control device and a Y-directional displacement control device; a roller-table assembly is arranged on the base plate and comprises a roller table, wherein the roller table is provided with an opposite-type photoelectric sensors and a wheel hub centring positioning device for centring positioning a wheel hub; a 3D scanning device, comprising a mounting bracket, wherein the bottom of the mounting bracket is controlled by the Y-directional displacement control device; a 3D scanner is mounted on the mounting bracket; a wheel hub scanning platform is arranged at an end of the roller-table assembly and is controlled by the X-directional displacement control device; and a robot is arranged on a first side of the wheel hub scanning platform, for conveying the wheel hubs after 3D scanning.

Abstract: An apparatus for thaw detection of a frozen item is disclosed, the apparatus comprising a housing container comprising a first transparent section and a second opaque section, at least one low density floating object and at least one high density object both encased within the housing container, wherein the housing container is filled with a filling mixture and melting of the filling mixture results in the at least one low density floating object and at least one high density object to be visible in the first transparent section of the housing container, thereby enabling thaw detection of the frozen item. Also disclosed is a method of manufacturing an apparatus for thaw detection of a frozen item.

Abstract: Novel conformationally-restricted analogues of sorafenib and regorafenib as selective kinase inhibitors for therapeutic formulations and methods for treating cancer.

Abstract: Novel heterocyclic fused systems are disclosed herein which possess numerous biological activities, including but not limited to antibacterial activity, and usefulness to the treatment of many disease states, such as pathogenic infections. In particular, new imidazoles are disclosed along with related processes of preparation and methods of use as antibacterial agents. The disclosed compounds were found to be active against several Gram-positive bacteria, including Enterococcus faecalis and Bacillus subtilis, and were also found to be active against several species of multi-drug resistant Staphylococcus, such as S. aureus, S. saprophyticus, S. haemolyticus, and S. epidermidis.